4
Changes in Ownership
PDS Biotechnology Corp Filed Acc 0001140361-15-037190
Director acquired 1,172,437 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Conti Kurt G · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-10-06 | Conversion : show line 1 in the form | +160,810 | 160,810 | D |
| 2015-10-06 | Conversion : show line 2 in the form | +163,731 | 324,541 | D |
| 2015-10-06 | Conversion : show line 3 in the form | +29,238 | 29,238 | I |
| 2015-10-06 | Conversion : show line 4 in the form | +14,619 | 14,619 | I |
| 2015-10-06 | Conversion : show line 5 in the form | +14,619 | 14,619 | I |
| 2015-10-06 | Conversion : show line 6 in the form | +789,420 | 789,420 | I |
Table II: Derivative
6 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2015-10-06 | Conversion : show line 7 in the form Series A Convertible Preferred Stock | −220,000 | 160,810 | 0 | D |
| 2015-10-06 | Conversion : show line 8 in the form Series B Convertible Preferred Stock | −224,000 | 163,731 | 0 | D |
| 2015-10-06 | Conversion : show line 9 in the form Series B Convertible Preferred Stock | −40,000 | 29,238 | 0 | I |
| 2015-10-06 | Conversion : show line 10 in the form Series B Convertible Preferred Stock | −20,000 | 14,619 | 0 | I |
| 2015-10-06 | Conversion : show line 11 in the form Series B Convertible Preferred Stock | −20,000 | 14,619 | 0 | I |
| 2015-10-06 | Conversion : show line 12 in the form Series B Convertible Preferred Stock | −1,080,000 | 789,420 | 0 | I |
Loading xslF345X03/doc1.xml…